Review



covid 19 vaccine trial data ar ti cl e  (Moderna)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Moderna covid 19 vaccine trial data ar ti cl e
    Covid 19 Vaccine Trial Data Ar Ti Cl E, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/covid+19+vaccine+trial+data+ar+ti+cl+e/19+clinical+covid+kidcove+trial+vaccine/pm41547989-132-0-17
    Average 86 stars, based on 1 article reviews
    covid 19 vaccine trial data ar ti cl e - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Association between COVID-19 vaccine efficacy and epidemic force of infection.
    Article Snippet: COVID-19 Vaccine Trial Data AR TI CL E IN P RE SS We incorporated data from the Moderna COVE trial of mRNA-1273 (CoVPN3001, ClinicalTrials.gov number: NCT04470427), 30,31 the AstraZeneca/Oxford AZD1222 trial of ChAdOx1 nCoV-19 (CoVPN3002, NCT04516746)32,33 and the Janssen/Johnson & Johnson ENSEMBLE trial of Ad26.COV2.S (CoVPN3003, NCT04505722).27 These trials were funded by the U.S. government and conducted under the Operation Warp Speed program, with operational leadership provided by the COVID-19 Prevention Network (CoVPN).34-37 Our analyses focused on the blinded periods of these trials (Table 3), during which participants received either mRNA-1273 (two doses, 28 days apart), ChAdOx1 nCoV-19 (two doses, 28 days apart), Ad26.COV2.S (one dose), or placebo.30,33,27 The primary endpoint was virologically confirmed COVID-19 with definitions slightly differed across the trials.38 As reported previously, the VE of mRNA-1273 was 93.2% (95% CI: 91.0-94.8) over a median follow-up of approximately 4 months after the second dose.30 For ChAdOx1 nCoV-19, VE was 67.0% (95% CI: 58.9-73.5) overall (i.e., among all participants, U.S.+ non-U.S.) and 72.3% (95% CI: 64.1-78.5) among U.S. participants,33 based on a median follow-up of 2.5 months after the second dose.



    Similar Products

    covid 19 vaccine trial data ar ti cl e  (Moderna)
    86
    Moderna covid 19 vaccine trial data ar ti cl e
    Covid 19 Vaccine Trial Data Ar Ti Cl E, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/covid+19+vaccine+trial+data+ar+ti+cl+e/19+clinical+covid+kidcove+trial+vaccine/pm41547989-132-0-17
    Average 86 stars, based on 1 article reviews
    covid 19 vaccine trial data ar ti cl e - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results